Andrew J. Davies
安德鲁·戴维斯
MBBS, PhD, FRCP, FRCPath
Professor of Medicine; Consultant Haematologist医学教授；血液科顾问医师
👥Biography 个人简介
Prof. Andrew Davies is a leading UK lymphoma researcher at the University of Southampton. His work focuses on optimizing R-CHOP-based therapy for DLBCL and understanding molecular mechanisms of resistance. He has led multiple UK-based and international trials and contributed to understanding prognostic biomarkers in aggressive lymphomas.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
R-CHOP Optimization and DLBCL Molecular Biology
Led clinical and translational studies examining how molecular subtypes and pharmacological modifications of R-CHOP affect outcomes in DLBCL, informing personalized treatment approaches and trial design.
Representative Works 代表性著作
Molecular Subtypes and Outcome in Diffuse Large B-Cell Lymphoma Treated with R-CHOP
Blood (2021)
Comprehensive analysis of cell-of-origin and genetic subtype impact on R-CHOP outcomes in DLBCL, supporting molecular stratification for future trials.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
关注 安德鲁·戴维斯 的研究动态
Follow Andrew J. Davies's research updates
留下邮箱，当我们发布与 Andrew J. Davies（University of Southampton and University Hospital Southampton NHS Foundation Trust）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment